{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:25:28Z","timestamp":1785252328693,"version":"3.55.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>HPV vaccines have been revolutionary in preventing HPV-related cervical cancer and reshaping the cervical cancer screening guidelines in the past decades. Yet, challenges persist in achieving universal accessibility and utilization. Since the COVID-19 pandemic, shifts have emerged in HPV vaccine research, implementation strategies, and the determinants shaping uptake and delivery, particularly from a global equity perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a scoping review examining English-language, peer-reviewed articles published following the onset of the COVID-19 pandemic until the end of 2024. It focuses on the human papillomavirus (HPV) vaccine and factors influencing its uptake. Articles were retrieved from PubMed and Embase databases and screened for relevance using predefined search terms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 2755 articles, 349 were included. We identified that most peer-reviewed articles focus on interventions and implementation strategies more than acknowledging geopolitical affairs, gender specificity, religious and ethical dimensions, medical mistrust, or healthcare discrimination. Most of the articles were cross-sectional in nature and most were funded by the National Cancer Institute. Interestingly, we found no peer-reviewed articles on the intersectionality of Judaism and HPV vaccine uptake, with a limited number on Islamic, Christian, or other religious intersectionality. Articles addressing how low- and middle-income countries could be equipped to develop and manage their own vaccine programs and manufacturing were largely absent; instead, cost-effectiveness research focused primarily on the vaccine\u2019s ability to reduce disease burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Post-pandemic research on HPV vaccination indicates that levels of hesitancy and uptake have remained relatively stable. However, the literature highlights persistent inconsistencies in how the vaccine is prioritized across communities, healthcare professionals, and health systems. Messaging regarding its importance for cancer prevention remains fragmented, while cost barriers and the absence of the vaccine from many national immunization schedules continue to limit access. Notably, ethical, religious, and cultural considerations receive limited attention in current research, despite the pandemic underscoring the global significance of these factors in shaping health behaviors. These findings suggest a need to re-examine how HPV vaccination is framed and advanced as a public health priority within diverse sociocultural and systemic contexts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12939-025-02669-y","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:44:37Z","timestamp":1762778677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0512-6924","authenticated-orcid":false,"given":"Sondos Al","family":"Sad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Labiqah","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masa","family":"Chamout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"4","key":"2669_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jiph.2023.02.014","volume":"16","author":"AA Oyouni","year":"2023","unstructured":"Oyouni AA. Human papillomavirus in cancer: infection, disease transmission, and progress in vaccines. J Infect Public Health. 2023 Apr 1;16(4):626\u201331.","journal-title":"J Infect Public Health"},{"issue":"6","key":"2669_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2020.9316","volume":"20","author":"A Petca","year":"2020","unstructured":"Petca A, Borislavschi A, Zvanca ME, Petca RC, Sandru F, Dumitrascu MC. Non-sexual HPV transmission and role of vaccination for a better future. Exp Ther Med. 2020 Dec 1;20(6):1.","journal-title":"Exp Ther Med"},{"issue":"2","key":"2669_CR3","first-page":"289","volume":"37","author":"RE Plotzker","year":"2023","unstructured":"Plotzker RE, Vaidya A, Pokharel U, Stier EA. Sexually transmitted human papillomavirus: update in epidemiology, prevention, and management. Infect Disease Clinics. 2023 Jun 1;37(2):289\u2013310.","journal-title":"Infect Disease Clinics"},{"issue":"suppl_8","key":"2669_CR4","doi-asserted-by":"publisher","first-page":"S849","DOI":"10.1093\/cid\/civ813","volume":"61","author":"IU Park","year":"2015","unstructured":"Park IU, Introcaso C, Dunne EF. Human papillomavirus and genital warts: a review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015 Dec 15;61(suppl_8):S849\u201355.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2669_CR5","first-page":"637","volume":"52","author":"D Boda","year":"2018","unstructured":"Boda D, Docea AO, Calina D, Ilie MA, Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE, Voiculescu V, Mamoulakis C. Human papilloma virus: apprehending the link with carcinogenesis and unveiling new research avenues. Int J Oncol. 2018 Mar 1;52(3):637\u201355.","journal-title":"Int J Oncol"},{"issue":"10451","key":"2669_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024 Aug 3;404(10451):435\u201344.","journal-title":"Lancet"},{"issue":"4","key":"2669_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C De Martel","year":"2017","unstructured":"De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, Country and HPV type. Int J Cancer. 2017 Aug 15;141(4):664\u201370.","journal-title":"Int J Cancer"},{"issue":"11","key":"2669_CR8","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1086\/428779","volume":"191","author":"PE Castle","year":"2005","unstructured":"Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis. 2005 Jun 1;191(11):1808\u201316.","journal-title":"J Infect Dis"},{"issue":"6","key":"2669_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/cid\/cix475","volume":"65","author":"EA Burger","year":"2017","unstructured":"Burger EA, Kim JJ, Sy S, Castle PE. Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer. Clin Infect Dis. 2017 Sep 15;65(6):893\u201399.","journal-title":"Clin Infect Dis"},{"issue":"S2","key":"2669_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.33594\/000000395","volume":"55","author":"L Lugovi\u0107-Mihi\u0107","year":"2021","unstructured":"Lugovi\u0107-Mihi\u0107 L, Cvitanovi\u0107 H, Djakovi\u0107 I, Kuna M, \u0160e\u0161erko A. The influence of psychological stress on HPV infection manifestations and carcinogenesis. Cell Physiol Biochem. 2021 Jul 1;55(S2):71\u201388.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"2669_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0168-1702(02)00188-0","volume":"89","author":"X Castellsagu\u00e9","year":"2002","unstructured":"Castellsagu\u00e9 X, Bosch FX, Mu\u00f1oz N. Environmental co-factors in HPV carcinogenesis. Virus Res. 2002 Nov 1;89(2):191\u201399.","journal-title":"Virus Res"},{"key":"2669_CR12","doi-asserted-by":"publisher","first-page":"106363","DOI":"10.1016\/j.ypmed.2020.106363","volume":"144","author":"CR Oliveira","year":"2021","unstructured":"Oliveira CR, Niccolai LM. Monitoring HPV vaccine impact on cervical disease: status and future directions for the era of cervical cancer elimination. Preventative Med. 2021 Mar 1;144:106363.","journal-title":"Preventative Med"},{"issue":"12","key":"2669_CR13","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1080\/14760584.2022.2129615","volume":"21","author":"W Wang","year":"2022","unstructured":"Wang W, Kothari S, Skufca J, Giuliano AR, Sundstr\u00f6m K, Nyg\u00e5rd M, Koro C, Baay M, Verstraeten T, Luxembourg A, Saah AJ. Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review. Expert Rev Vaccines. 2022 Dec 2;21(12):1799\u2013817.","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"2669_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/vaccines11061083","volume":"11","author":"C Rosado","year":"2023","unstructured":"Rosado C, Fernandes \u00c2R, Rodrigues AG, Lisboa C. Impact of human papillomavirus vaccination on male disease: a systematic review. Vaccines. 2023 Jun 9;11(6):1083.","journal-title":"Vaccines"},{"issue":"4","key":"2669_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5694\/j.1326-5377.2008.tb01593.x","volume":"188","author":"SR Skinner","year":"2008","unstructured":"Skinner SR, Garland SM, Stanley MA, Pitts M, Quinn MA. Human papillomavirus vaccination for the prevention of cervical neoplasia: Is it appropriate to vaccinate women older than 26? Med J Aust. 2008 Feb;188(4):238\u201342.","journal-title":"Med J Aust"},{"issue":"5","key":"2669_CR16","doi-asserted-by":"publisher","first-page":"2078626","DOI":"10.1080\/21645515.2022.2078626","volume":"18","author":"I Maldonado","year":"2022","unstructured":"Maldonado I, Plata M, Gonzalez M, Correa A, Nossa C, Giuliano AR, Joura EA, Ferenczy A, Ronnett BM, Stoler MH, Jin Zhou H. Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27\u201345 years. Hum Vaccines Immunotherapeutics. 2022 Nov 30;18(5):2078626.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"2669_CR17","unstructured":"Cancer Today. (n.d.). https:\/\/gco.iarc.who.int\/today\/en\/fact-sheets-cancers#a-to-z-cancers."},{"key":"2669_CR18","unstructured":"Cancers linked with HPV each year. 2023 November 14. Cancer. https:\/\/www.cdc.gov\/cancer\/hpv\/cases.html."},{"key":"2669_CR19","doi-asserted-by":"publisher","first-page":"102467","DOI":"10.1016\/j.ctrv.2022.102467","volume":"111","author":"G Giannone","year":"2022","unstructured":"Giannone G, Giuliano AR, Bandini M, Marandino L, Raggi D, Earle W, Ayres B, Pettaway CA, McNeish IA, Spiess PE, Necchi A. HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage. Cancer Treat Rev. 2022 Dec 1;111:102467.","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"2669_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jnci\/djaa209","volume":"113","author":"C Dehlendorff","year":"2021","unstructured":"Dehlendorff C, Baandrup L, Kjaer SK. Real-world effectiveness of human papillomavirus vaccination against vulvovaginal high-grade precancerous lesions and cancers. JNCI: J Natl Cancer Inst. 2021 Jul 1;113(7):869\u201374.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"6","key":"2669_CR21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/ijc.30821","volume":"141","author":"MT Faber","year":"2017","unstructured":"Faber MT, Sand FL, Albieri V, Norrild B, Kj\u00e6r SK, Verdoodt F. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Int J Cancer. 2017 Sep 15;141(6):1161\u201369.","journal-title":"Int J Cancer"},{"key":"2669_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bpobgyn.2020.02.009","volume":"65","author":"A Athanasiou","year":"2020","unstructured":"Athanasiou A, Bowden S, Paraskevaidi M, Fotopoulou C, Martin-Hirsch P, Paraskevaidis E, Kyrgiou M. HPV vaccination and cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2020 May 1;65:109\u201324.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"12","key":"2669_CR23","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/vaccines9121413","volume":"9","author":"S Kamolratanakul","year":"2021","unstructured":"Kamolratanakul S, Pitisuttithum P. Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccine. 2021 Nov 30;9(12):1413.","journal-title":"Vaccine"},{"issue":"1","key":"2669_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2334-13-39","volume":"13","author":"H Patel","year":"2013","unstructured":"Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013 Jan 25;13(1):39.","journal-title":"BMC Infect Dis"},{"key":"2669_CR25","doi-asserted-by":"crossref","unstructured":"A\u011far E, Aker S\u015e. Association of HPV and sexually transmitted infections among patients with genital warts and asymptomatic individuals: a cross-sectional study. Eur J Gynaecol Oncol. 2023 Aug 1;44(4).","DOI":"10.1136\/ijgc-2023-ESGO.743"},{"issue":"2","key":"2669_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.vaccine.2021.11.062","volume":"40","author":"C Mu\u00f1oz-Quiles","year":"2022","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, D\u00edez-Domingo J, Rodrigo-Casares V, Orrico-S\u00e1nchez A. Human papillomavirus vaccines effectiveness to prevent genital warts: a population-based study using health system integrated databases, 2009-2017. Vaccine. 2022 Jan 21;40(2):316\u201324.","journal-title":"Vaccine"},{"key":"2669_CR27","doi-asserted-by":"publisher","first-page":"552028","DOI":"10.3389\/fpubh.2020.552028","volume":"8","author":"AJ Kombe Kombe","year":"2021","unstructured":"Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2021 Jan 20;8:552028.","journal-title":"Front Public Health"},{"issue":"Supplement_2","key":"2669_CR28","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1093\/cid\/ciac044","volume":"74","author":"LF Barroso","year":"2022","unstructured":"Barroso LF, Stier EA, Hillman R, Palefsky J. Anal cancer screening and prevention: summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infection guidelines. Clin Infect Dis. 2022 Apr 15;74(Supplement_2):S179\u201392.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2669_CR29","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/14760584.2022.2075850","volume":"21","author":"A Mehta","year":"2022","unstructured":"Mehta A, Markman B, Rodriguez-Cintron W. Don\u2019t jump down my throat: gender gap in HPV vaccinations risk long term cancer threats. Expert Rev Vaccines. 2022 Aug 3;21(8):1045\u201353.","journal-title":"Expert Rev Vaccines"},{"key":"2669_CR30","doi-asserted-by":"crossref","unstructured":"Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014 Nov;41(11):660.","DOI":"10.1097\/OLQ.0000000000000193"},{"issue":"12","key":"2669_CR31","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1002\/ijc.29082","volume":"136","author":"AR Giuliano","year":"2015","unstructured":"Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S. EUROGIN, 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015 Jun 15;136(12):2752\u201360.","journal-title":"Int J Cancer"},{"issue":"1","key":"2669_CR32","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1186\/s12889-021-12147-z","volume":"21","author":"B Poirier","year":"2021","unstructured":"Poirier B, Sethi S, Garvey G, Hedges J, Canfell K, Smith M, Ju X, Jamieson L. HPV vaccine: uptake and understanding among global Indigenous communities-a qualitative systematic review. BMC Public Health. 2021 Nov 10;21(1):2062.","journal-title":"BMC Public Health"},{"issue":"1","key":"2669_CR33","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1186\/s12889-023-15876-5","volume":"23","author":"C Escoffery","year":"2023","unstructured":"Escoffery C, Petagna C, Agnone C, Perez S, Saber LB, Ryan G, Dhir M, Sekar S, Yeager KA, Biddell CB, Madhivanan P. A systematic review of interventions to promote HPV vaccination globally. BMC Public Health. 2023 Jun 29;23(1):1262.","journal-title":"BMC Public Health"},{"issue":"1","key":"2669_CR34","doi-asserted-by":"publisher","first-page":"e0291990","DOI":"10.1371\/journal.pone.0291990","volume":"19","author":"D Guillaume","year":"2024","unstructured":"Guillaume D, Waheed DE, Schleiff M, Muralidharan KK, Vorsters A, Limaye RJ. Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries. PLoS One. 2024 Jan 16;19(1):e0291990.","journal-title":"PLoS One"},{"issue":"1","key":"2669_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12889-022-12573-7","volume":"22","author":"B Anuforo","year":"2022","unstructured":"Anuforo B, McGee-Avila JK, Toler L, Xu B, Kohler RE, Manne S, Tsui J. Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey. BMC Public Health. 2022 Jan 29;22(1):195.","journal-title":"BMC Public Health"},{"issue":"5","key":"2669_CR36","first-page":"479","volume":"34","author":"A Adegboyega","year":"2023","unstructured":"Adegboyega A, Obielodan O, Wiggins AT, Dignan M, Williams LB. Beliefs and knowledge related to human papillomavirus (HPV) vaccine among African Americans and African immigrants young adults. Cancer Cause Control. 2023 May;34(5):479\u201389.","journal-title":"Cancer Cause Control"},{"issue":"2","key":"2669_CR37","doi-asserted-by":"publisher","first-page":"2225388","DOI":"10.1080\/21645515.2023.2225388","volume":"19","author":"GW Ryan","year":"2023","unstructured":"Ryan GW, Miotto MB, McReynolds C, Lemon SC, Pbert L, Trivedi M. Pediatricians\u2019 perspectives on COVID-19 and HPV vaccine hesitancy. Hum Vaccines Immunotherapeutics. 2023 Aug 1;19(2):2225388.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"1","key":"2669_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13690-024-01318-0","volume":"82","author":"P Nguyen","year":"2024","unstructured":"Nguyen P, Calderon-Mora J, Singh V, Hernandez A, Roy S, Molokwu J. Impact of the COVID-19 pandemic on HPV vaccine uptake in a predominantly Hispanic Border Community: a retrospective cross-sectional analysis of the\u201cTiempo de Vacunarte Program\u201d. Arch Public Health. 2024 Jun 24;82(1):96.","journal-title":"Arch Public Health"},{"key":"2669_CR39","doi-asserted-by":"publisher","first-page":"e85743","DOI":"10.7554\/eLife.85743","volume":"12","author":"EK Vraga","year":"2023","unstructured":"Vraga EK, Brady SS, Gansen C, Khan EM, Bennis SL, Nones M, Tang R, Srivastava J, Kulasingam S. A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19. Elife. 2023 Aug 18;12:e85743.","journal-title":"Elife"},{"key":"2669_CR40","unstructured":"Covidence systematic review software. Veritas Health Innovation, Melbourne, Australia. Available at: https:\/\/www.covidence.org."},{"key":"2669_CR41","doi-asserted-by":"publisher","first-page":"106335","DOI":"10.1016\/j.ypmed.2020.106335","volume":"144","author":"VD Tsu","year":"2021","unstructured":"Tsu VD, LaMontagne DS, Atuhebwe P, Bloem PN, Ndiaye C. National implementation of HPV vaccination programs in low-resource countries: lessons, challenges, and future prospects. Preventative Med. 2021 Mar 1;144:106335.","journal-title":"Preventative Med"},{"key":"2669_CR42","doi-asserted-by":"publisher","first-page":"1150238","DOI":"10.3389\/fimmu.2023.1150238","volume":"14","author":"N Ebrahimi","year":"2023","unstructured":"Ebrahimi N, Yousefi Z, Khosravi G, Malayeri FE, Golabi M, Askarzadeh M, Shams MH, Ghezelbash B, Eskandari N. Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective. Front Immunol. 2023 May 12;14:1150238.","journal-title":"Front Immunol"},{"issue":"10","key":"2669_CR43","doi-asserted-by":"publisher","first-page":"e788","DOI":"10.1016\/S2468-2667(23)00180-9","volume":"8","author":"\u00c9 B\u00e9nard","year":"2023","unstructured":"B\u00e9nard \u00c9, Drolet M, Laprise JF, Gingras G, Jit M, Boily MC, Bloem P, Brisson M. Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis. Lancet Public Health. 2023 Oct 1;8(10):e788\u201399.","journal-title":"Lancet Public Health"},{"key":"2669_CR44","unstructured":"UNICEF. COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows. Available: COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows. Accessed 19 Jul 2021."},{"key":"2669_CR45","doi-asserted-by":"publisher","first-page":"A85","DOI":"10.1016\/j.vaccine.2021.07.027","volume":"40","author":"E Vodicka","year":"2022","unstructured":"Vodicka E, Nonvignon J, Antwi-Agyei KO, Bawa J, Clark A, Pecenka C, LaMontagne DS. The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana. Vaccine. 2022 Mar 31;40:A85\u201393.","journal-title":"Vaccine"},{"issue":"1","key":"2669_CR46","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1186\/s12889-022-13975-3","volume":"22","author":"M Egbon","year":"2022","unstructured":"Egbon M, Ojo T, Aliyu A, Bagudu ZS. Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community. BMC Public Health. 2022 Aug 24;22(1):1611.","journal-title":"BMC Public Health"},{"issue":"1","key":"2669_CR47","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/S2214-109X(22)00475-2","volume":"11","author":"\u00c9 B\u00e9nard","year":"2023","unstructured":"B\u00e9nard \u00c9, Drolet M, Laprise JF, Jit M, Prem K, Boily MC, Brisson M. Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis. Lancet Global Health. 2023 Jan 1;11(1):e48\u201358.","journal-title":"Lancet Global Health"},{"issue":"6","key":"2669_CR48","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/00219096221079310","volume":"58","author":"B Singh","year":"2023","unstructured":"Singh B, Singh S, Singh B, Chattu VK. India\u2019s neighbourhood vaccine diplomacy during COVID-19 pandemic: humanitarian and geopolitical perspectives. J Asian Afr Stud. 2023 Sep;58(6):1021\u201337.","journal-title":"J Asian Afr Stud"},{"key":"2669_CR49","unstructured":"de Cosio FG, Diaz-Apodaca B, Ojeda-Casares H, Ambriz L. An unorthodox Geopolitical-epidemiological approach to address the COVID-19 global vaccination distribution. J Comm Med Pub Health Rep. 2(4)."},{"issue":"6","key":"2669_CR50","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.3802\/jgo.2024.35.e85","volume":"35","author":"W Termrungruanglert","year":"2024","unstructured":"Termrungruanglert W, Khemapech N, Vasuratna A, Havanond P, Tantitamit T. Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low\/middle-income country setting. J Gynecol Oncol. 2024 Apr 18;35(6):e85.","journal-title":"J Gynecol Oncol"},{"key":"2669_CR51","first-page":"100534","volume":"20","author":"M Mvundura","year":"2024","unstructured":"Mvundura M, Slavkovsky R, Debellut F, Naddumba T, Pecenka C, Lamontagne DS. Determinants of costs of human papillomavirus vaccine delivery in six low-and middle-income countries. Vaccine: X. 2024 Oct 1;20:100534.","journal-title":"Vaccine: X"},{"issue":"3","key":"2669_CR52","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/10810730.2023.2191224","volume":"28","author":"SJ Hong","year":"2023","unstructured":"Hong SJ, Kim Y. Relationship of exposure to contradictory information and information insufficiency to decision-making about HPV vaccination among South Korean college women. J Health Commun. 2023 Mar 4;28(3):156\u201367.","journal-title":"J Health Commun"},{"key":"2669_CR53","doi-asserted-by":"crossref","unstructured":"Abbas K, Yoo KJ, Prem K, Jit M. Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 Countries by global, regional, and income levels, 2010-22. A modelling study. EClinicalMedicine. 2024 Apr 1;70.","DOI":"10.2139\/ssrn.4544774"},{"key":"2669_CR54","unstructured":"World bank support for country access to COVID-19 vaccines [Internet]. World Bank. 2016. Available from: https:\/\/www.worldbank.org\/en\/who-we-are\/news\/coronavirus-covid19\/world-bank-support-for-country-access-to-covid-19-vaccines?utm_source=chatgpt.com."},{"key":"2669_CR55","unstructured":"AP News. Pakistan vaccinates 9 million girls against cervical cancer despite online backlash. Published 2023. Available from: https:\/\/apnews.com\/article\/fe5a33137a5f7565d9f0fea3087fb068."},{"key":"2669_CR56","unstructured":"Reuters Staff. World Bank, Gates, UN pledge close to $600m to end cervical cancer. Reuters [Internet]. 2024 Mar 6. Available from: https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/world-bank-gates-un-pledge-close-600m-end-cervical-cancer-2024-03-05\/."},{"key":"2669_CR57","unstructured":"Real Instituto Elcano. Preventing cervical cancer in Africa: why scaling HPV vaccination is a priority. Published 2022. Available from: https:\/\/blogs.worldbank.org\/en\/health\/Preventing-cervical-cancer-in-Africa-Why-scaling-HPV-vaccination-priority."},{"key":"2669_CR58","unstructured":"Time. Vaccine inequity: a threat to Africa\u2019s recovery from COVID-19. Published 2021. Available from: https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-023-00564-2."},{"issue":"4","key":"2669_CR59","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0272989X241240466","volume":"44","author":"Y Gendler","year":"2024","unstructured":"Gendler Y, Blau A. Exploring cultural and religious effects on HPV vaccination decision making using a Web-Based decision aid: a Quasi-experimental study. Med Decis Mak. 2024 May;44(4):426\u201336.","journal-title":"Med Decis Mak"},{"issue":"6","key":"2669_CR60","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/ajco.13513","volume":"17","author":"AT Ver","year":"2021","unstructured":"Ver AT, Notarte KI, Velasco JV, Buac KM, Nazareno Iii J, Loza\u00f1es JA, Antonio D, Bacorro W. A systematic review of the barriers to implementing human papillomavirus vaccination programs in low-and middle-income countries in the Asia-Pacific. Asia Pac J Clin Oncol. 2021 Dec;17(6):530\u201345.","journal-title":"Asia Pac J Clin Oncol"},{"key":"2669_CR61","unstructured":"World Health Organization. Global market study: HPV vaccines (working document). World Health Organ. 2022. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/mi4a\/who-mi4a-global-market-study-hpv.pdf?sfvrsn=649561b3_1%26download=true."},{"issue":"11","key":"2669_CR62","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S1473-3099(23)00275-X","volume":"23","author":"FC Zhu","year":"2023","unstructured":"Zhu FC, Zhong GH, Huang WJ, Chu K, Zhang L, Bi ZF, Zhu KX, Chen Q, Zheng TQ, Zhang ML, Liu S. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18\u201326 years in China: a randomised blinded clinical trial. Lancet Infect Dis. 2023 Nov 1;23(11):1313\u201322.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"2669_CR63","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.vaccine.2024.02.077","volume":"42","author":"K Zaman","year":"2024","unstructured":"Zaman K, Schuind AE, Adjei S, Antony K, Aponte JJ, Buabeng PB, Qadri F, Kemp TJ, Hossain L, Pinto LA, Sukraw K. Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9\u201314 years of age: interim analysis from a phase 3 clinical trial. Vaccine. 2024 Apr 2;42(9):2290\u201398.","journal-title":"Vaccine"},{"issue":"1","key":"2669_CR64","doi-asserted-by":"publisher","first-page":"e2498","DOI":"10.1002\/rmv.2498","volume":"34","author":"I Hadj Hassine","year":"2024","unstructured":"Hadj Hassine I, Ben M\u2019hadheb, Almalki MA, Gharbi J. Virus-like particles as powerful vaccination strategy against human viruses. Rev Med Virol. 2024 Jan;34(1):e2498.","journal-title":"Rev Med Virol"},{"issue":"2","key":"2669_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/cmrp.cmrp_28_23","volume":"13","author":"S Rajaram","year":"2023","unstructured":"Rajaram S, Sahoo I, Heda A, Singh L. Human papillomavirus vaccine: an update on recent developments and review of real world data on efficacy. Curr Med Res Pract. 2023 Mar 1;13(2):62\u201368.","journal-title":"Curr Med Res Pract"},{"key":"2669_CR66","unstructured":"GlaxoSmithKline Inc. Cervarix: human papillomavirus vaccine types 16 and 18 (Recombinant, AS04-adjuvanted). Product monograph. Mississauga, ON: GlaxoSmithKline Inc; 2010 Feb 3 [updated 2024 May 17] Available from: https:\/\/ca.gsk.com\/media\/6236\/cervarix.pdf."},{"key":"2669_CR67","unstructured":"Walvax Biotechnology Co., Ltd. New HPV vaccine from Zerun Bio receives WHO prequalification. Published 2024 Aug 30. Available from: https:\/\/en.walvax.com\/news\/new-hpv-vaccine-from-zerun-bio-who-pq.html."},{"key":"2669_CR68","unstructured":"Merck & Co., Inc. GARDASIL\u00ae9 (Human Papillomavirus 9-valent Vaccine, Recombinant). Prescribing information. Whitehouse Station, NJ: Merck & Co., Inc. 2025 Sep 19. Available from: https:\/\/www.merck.ca\/STATIC\/PDF\/GARDASIL_9-PM_E.PDF."},{"key":"2669_CR69","doi-asserted-by":"crossref","unstructured":"Alhamlan FS, Alfageeh MB, Al Mushait MA, Al-Badawi IA, Al-Ahdal MN. Human papillomavirus-associated cancers. Microb Pathogen: Infect Immun. 2021;1\u20134.","DOI":"10.1007\/978-3-030-67452-6_1"},{"issue":"8","key":"2669_CR70","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s10147-023-02340-y","volume":"28","author":"N Egawa","year":"2023","unstructured":"Egawa N. Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body. Int J Clin Oncol. 2023 Aug;28(8):956\u201364.","journal-title":"Int J Clin Oncol"},{"key":"2669_CR71","doi-asserted-by":"publisher","first-page":"L16","DOI":"10.1016\/j.vaccine.2008.06.008","volume":"26","author":"M Almonte","year":"2008","unstructured":"Almonte M, Albero G, Molano M, Carcamo C, Garc\u00eda PJ, P\u00e9rez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine. 2008 Aug 19;26:L16\u201336.","journal-title":"Vaccine"},{"issue":"8","key":"2669_CR72","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.3390\/cancers12082201","volume":"12","author":"F Aguayo","year":"2020","unstructured":"Aguayo F, Mu\u00f1oz JP, Perez-Dominguez F, Carrillo-Beltr\u00e1n D, Oliva C, Calaf GM, Blanco R, Nu\u00f1ez-Acurio D. High-risk human papillomavirus and tobacco smoke interactions in epithelial carcinogenesis. Cancers. 2020 Aug 6;12(8):2201.","journal-title":"Cancers"},{"issue":"12","key":"2669_CR73","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/jnci\/djad169","volume":"115","author":"ZS Zumsteg","year":"2023","unstructured":"Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, Gay C, Lu DJ, Chen MM, Chaturvedi AK, Goodman MT. Global epidemiologic patterns of oropharyngeal cancer incidence trends. JNCI: J Natl Cancer Inst. 2023 Dec 1;115(12):1544\u201354.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"2669_CR74","first-page":"1","volume":"17","author":"T Malag\u00f3n","year":"2024","unstructured":"Malag\u00f3n T, Franco EL, Tejada R, Vaccarella S. Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nat Rev Clin Oncol. 2024 May;17:1\u20137.","journal-title":"Nat Rev Clin Oncol"},{"key":"2669_CR75","doi-asserted-by":"publisher","first-page":"101278","DOI":"10.1016\/j.ssmph.2022.101278","volume":"20","author":"JD Allen","year":"2022","unstructured":"Allen JD, Fu Q, Shrestha S, Nguyen KH, Stopka TJ, Cuevas A, Corlin L. Medical mistrust, discrimination, and COVID-19 vaccine behaviors among a national sample US adults. SSM-Popul Health. 2022 Dec 1;20:101278.","journal-title":"SSM-Popul Health"},{"key":"2669_CR76","doi-asserted-by":"publisher","first-page":"1422839","DOI":"10.3389\/fonc.2024.1422839","volume":"14","author":"MM Sleiman Jr","year":"2025","unstructured":"Sleiman Jr MM, Yockel MR, Liu M, Wendolowski J, Adams-Campbell LL, Dash C, Carter-Bawa L, Aragones A, Arumani S, Tercyak KP. Impact of social determinants and medical mistrust on parent-child HPV vaccination in economically disadvantaged communities: implications for cancer prevention. Front Oncol. 2025 Jan 23;14:1422839.","journal-title":"Front Oncol"},{"issue":"5","key":"2669_CR77","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1056\/NEJMpv2035827","volume":"384","author":"SS Bajaj","year":"2021","unstructured":"Bajaj SS, Stanford FC. Beyond Tuskegee-vaccine distrust and everyday racism. N Engl J Med. 2021 Feb 4;384(5):e12.","journal-title":"N Engl J Med"},{"issue":"1","key":"2669_CR78","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10865-022-00283-9","volume":"46","author":"J Tsui","year":"2023","unstructured":"Tsui J, Martinez B, Shin MB, Allee-Munoz A, Rodriguez I, Navarro J, Thomas-Barrios KR, Kast WM, Baezconde-Garbanati L. Understanding medical mistrust and HPV vaccine hesitancy among multiethnic parents in Los Angeles. J Behavioral Med. 2023 Apr;46(1):100\u201315.","journal-title":"J Behavioral Med"},{"key":"2669_CR79","volume-title":"Vulnerable populations in the United States","author":"L Shi","year":"2021","unstructured":"Shi L, Stevens GD. Vulnerable populations in the United States. John Wiley & Sons; 2021 Feb 10."},{"issue":"1","key":"2669_CR80","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12889-024-18166-w","volume":"24","author":"X Chen","year":"2024","unstructured":"Chen X, Wang L, Huang Y, Zhang L. Risk perception and trust in the relationship between knowledge and HPV vaccine hesitancy among female university students in China: a cross-sectional study. BMC Public Health. 2024 Mar 1;24(1):667.","journal-title":"BMC Public Health"},{"issue":"26","key":"2669_CR81","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1016\/j.vaccine.2018.02.043","volume":"36","author":"KZ Apaydin","year":"2018","unstructured":"Apaydin KZ, Fontenot HB, Shtasel D, Dale SK, Borba CP, Lathan CS, Panther L, Mayer KH, Keuroghlian AS. Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center. Vaccine. 2018 Jun 18;36(26):3868\u201375.","journal-title":"Vaccine"},{"key":"2669_CR82","doi-asserted-by":"publisher","first-page":"114871","DOI":"10.1016\/j.socscimed.2022.114871","volume":"301","author":"D Zubizarreta","year":"2022","unstructured":"Zubizarreta D, Beccia AL, Trinh MH, Reynolds CA, Reisner SL, Charlton BM. Human papillomavirus vaccination disparities among US college students: an intersectional Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA). Soc Sci Med. 2022 May 1;301:114871.","journal-title":"Soc Sci Med"},{"issue":"1","key":"2669_CR83","doi-asserted-by":"publisher","first-page":"2300879","DOI":"10.1080\/21645515.2023.2300879","volume":"20","author":"A Anandarajah","year":"2024","unstructured":"Anandarajah A, Shato T, Humble S, Barnette AR, Brandt HM, Klesges LM, Sanders Thompson VL, Silver MI. The association of caregiver attitudes, information sources, and trust with HPV vaccine initiation among adolescents. Hum Vaccines Immunotherapeutics. 2024 Dec 31;20(1):2300879.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"4","key":"2669_CR84","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/trgh.2021.0077","volume":"8","author":"M Ag\u00e9nor","year":"2023","unstructured":"Ag\u00e9nor M, Lett E, Murchison GR, Tabaac AR, Dowshen N, Gordon AR. Gender-related health care discrimination and human papillomavirus vaccination among transgender and nonbinary young adults in the United States. Transgender Health. 2023 Aug 1;8(4):389\u201395.","journal-title":"Transgender Health"},{"issue":"2","key":"2669_CR85","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3934\/publichealth.2021027","volume":"8","author":"N Harrington","year":"2021","unstructured":"Harrington N, Chen Y, O\u2019Reilly AM, Fang CY. The role of trust in HPV vaccine uptake among racial and ethnic minorities in the United States: a narrative review. AIMS Public Health. 2021;8(2):352\u201368. https:\/\/doi.org\/10.3934\/publichealth.2021027.","journal-title":"AIMS Public Health"},{"issue":"1","key":"2669_CR86","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0360-3016(97)00835-3","volume":"40","author":"OW Brawley","year":"1998","unstructured":"Brawley OW. The study of untreated syphilis in the negro male. Int J Radiat Oncol Biol Phys. 1998;40(1):5\u20138. https:\/\/doi.org\/10.1016\/s0360-3016(97)00835-3.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2669_CR87","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s40615-021-01214-1","volume":"10","author":"CW Wheldon","year":"2023","unstructured":"Wheldon CW, Eaton LA, Watson RJ. Predisposing, enabling, and need-related factors associated with human papillomavirus vaccination intentions and uptake among black and hispanic sexual and gender diverse adults in the USA. J Racial Ethnic Health Disparities. 2023 Feb;10(1):237\u201343.","journal-title":"J Racial Ethnic Health Disparities"},{"key":"2669_CR88","unstructured":"Exploring mother-daughter communication and social media influence on HPV vaccine refusal for daughters aged 9\u201317 years in a cross-sectional survey of 11, 728 mothers in China."},{"issue":"5","key":"2669_CR89","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/vaccines12050529","volume":"12","author":"PY Lin","year":"2024","unstructured":"Lin PY, Liu TL, Chen LM, Liu MJ, Chang YP, Tsai CS, Yen CF. Determinants of parental intention to vaccinate young adolescent girls against the human papillomavirus in Taiwan: an online survey study. Vaccines. 2024 May 11;12(5):529.","journal-title":"Vaccines"},{"issue":"1","key":"2669_CR90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10865-022-00316-3","volume":"46","author":"JA Manganello","year":"2023","unstructured":"Manganello JA, Chiang SC, Cowlin H, Kearney MD, Massey PM. HPV and COVID-19 vaccines: social media use, confidence, and intentions among parents living in different community types in the United States. J Behavioral Med. 2023 Apr;46(1):212\u201328.","journal-title":"J Behavioral Med"},{"issue":"5","key":"2669_CR91","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s10900-024-01348-3","volume":"49","author":"G Almatkyzy","year":"2024","unstructured":"Almatkyzy G, Vaughn A, Mirza D, Mojica CM. Online scan of campus health resources and HPV vaccination information on college and University Websites in the State of Oregon. J Commun Health. 2024 Oct;49(5):926\u201334.","journal-title":"J Commun Health"},{"issue":"1","key":"2669_CR92","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12916-024-03538-1","volume":"22","author":"Z Lin","year":"2024","unstructured":"Lin Z, Chen S, Su L, Liao Y, Chen H, Hu Z, Chen Z, Fang Y, Liang X, Chen J, Luo B. Influences of HPV disease perceptions, vaccine accessibility, and information exposure on social media on HPV vaccination uptake among 11, 678 mothers with daughters aged 9\u201317 years in China: a cross-sectional study. BMC Med. 2024 Aug 13;22(1):328.","journal-title":"BMC Med"},{"key":"2669_CR93","doi-asserted-by":"publisher","first-page":"126571","DOI":"10.1016\/j.vaccine.2024.126571","volume":"44","author":"E Liebermann","year":"2025","unstructured":"Liebermann E, Kornides M, Matsunaga M, Lim E, Zimet G, Glauberman G, Kronen C, Fontenot HB. Use of social media and its influence on HPV vaccine hesitancy: US National Online Survey of mothers of adolescents, 2023. Vaccine. 2025 Jan 12;44:126571.","journal-title":"Vaccine"},{"key":"2669_CR94","doi-asserted-by":"publisher","first-page":"100329","DOI":"10.1016\/j.pecinn.2024.100329","volume":"5","author":"D Boatman","year":"2024","unstructured":"Boatman D, Jarrett Z, Starkey A, Conn ME, Kennedy-Rea S. HPV vaccine misinformation on social media: a multi-method qualitative analysis of comments across three platforms. PEC Innov. 2024 Dec 15;5:100329.","journal-title":"PEC Innov"},{"key":"2669_CR95","doi-asserted-by":"publisher","first-page":"126575","DOI":"10.1016\/j.vaccine.2024.126575","volume":"46","author":"PM Massey","year":"2025","unstructured":"Massey PM, Murray RM, Kostizak K, Lo WJ, Yudell M. Exploring the ethics of using fictional stories for health education on social media to share information and emotions about the HPV vaccine: a cross-sectional study with interdisciplinary health experts. Vaccine. 2025 Feb 6;46:126575.","journal-title":"Vaccine"},{"issue":"2","key":"2669_CR96","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/vaccines12020187","volume":"12","author":"M Montalti","year":"2024","unstructured":"Montalti M, Salussolia A, Capodici A, Scognamiglio F, Di Valerio Z, La Fauci G, Sold\u00e0 G, Fantini MP, Odone A, Costantino C, Leask J. Human papillomavirus (HPV) vaccine coverage and confidence in Italy: a nationwide cross-sectional study, the OBVIOUS project. Vaccines. 2024 Feb 12;12(2):187.","journal-title":"Vaccines"},{"issue":"2","key":"2669_CR97","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10935-022-00711-1","volume":"44","author":"MY G\u00fcrsoy","year":"2023","unstructured":"G\u00fcrsoy MY, Sa\u011fta\u015f F. Human papillomavirus vaccination in male university students in Turkey: coverage rate, barriers, and associated factors. J Prev. 2023 Apr;44(2):181\u201391.","journal-title":"J Prev"},{"issue":"2","key":"2669_CR98","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1086\/713037","volume":"7","author":"BF Churchill","year":"2021","unstructured":"Churchill BF. Insurance coverage, provider contact, and take-up of the HPV vaccine. Am J Health Econ. 2021 Mar 1;7(2):222\u201347.","journal-title":"Am J Health Econ"},{"issue":"1","key":"2669_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-08561-4","volume":"20","author":"A Faisal-Cury","year":"2020","unstructured":"Faisal-Cury A, Levy RB, Tourinho MF, Grangeiro A, Eluf-Neto J. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program. BMC Public Health. 2020 Dec;20(1):1\u20132.","journal-title":"BMC Public Health"},{"key":"2669_CR100","doi-asserted-by":"publisher","first-page":"126581","DOI":"10.1016\/j.vaccine.2024.126581","volume":"46","author":"J Cunningham-Erves","year":"2025","unstructured":"Cunningham-Erves J, Sanderson M, Jin SW, Davis J, Brandt HM. Predictors of HPV vaccination coverage among adolescents in Tennessee during the COVID-19 pandemic: a cross-sectional study. Vaccine. 2025 Feb 6;46:126581.","journal-title":"Vaccine"},{"issue":"7","key":"2669_CR101","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.vaccine.2023.01.011","volume":"41","author":"H Sell","year":"2023","unstructured":"Sell H, Paudel YR, Voaklander D, MacDonald SE. School immunization coverage in adolescents during the COVID-19 pandemic: a retrospective cohort study. Vaccine. 2023 Feb 10;41(7):1333\u201341.","journal-title":"Vaccine"},{"key":"2669_CR102","unstructured":"Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states."},{"issue":"2","key":"2669_CR103","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.amepre.2024.03.008","volume":"67","author":"Y Song","year":"2024","unstructured":"Song Y, Choi W, Shim E. Cost-effectiveness of human papillomavirus vaccination in the UK: two versus single-dose of nonavalent HPV vaccination. Am J Preventative Med. 2024 Aug 1;67(2):231\u201340.","journal-title":"Am J Preventative Med"},{"issue":"7","key":"2669_CR104","doi-asserted-by":"publisher","first-page":"e35136","DOI":"10.1097\/MD.0000000000035136","volume":"103","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhang W, Xu T, Song J, Li S, Zhang H, Fu X. Analysis of the current state of cervical cancer prevention awareness and its influencing factors among rural women in Luohe City. Medicine. 2024 Feb 16;103(7):e35136.","journal-title":"Medicine"},{"issue":"11","key":"2669_CR105","doi-asserted-by":"publisher","first-page":"e068212","DOI":"10.1136\/bmjopen-2022-068212","volume":"12","author":"L Elit","year":"2022","unstructured":"Elit L, Ngalla C, Afugchwi GM, Tum E, Domgue JF, Nouvet E. Assessing knowledge, attitudes and belief toward HPV vaccination of parents with children aged 9\u201314 years in rural communities of Northwest Cameroon: a qualitative study. BMJ Open. 2022 Nov 1;12(11):e068212.","journal-title":"BMJ Open"},{"issue":"1","key":"2669_CR106","doi-asserted-by":"publisher","first-page":"2347018","DOI":"10.1080\/21645515.2024.2347018","volume":"20","author":"OO Odebunmi","year":"2024","unstructured":"Odebunmi OO, Spees LP, Biddell CB, Yemeke T, Yanguela J, Higgins C, Gilkey MB, Ozawa S, Wheeler SB. Benefits, challenges, and strategies related to using presumptive recommendations for HPV vaccination: a qualitative study with rural and non-rural-serving primary care professionals. Hum Vaccines Immunotherapeutics. 2024 Dec 31;20(1):2347018.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"3","key":"2669_CR107","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/vaccines10030397","volume":"10","author":"DS Redd","year":"2022","unstructured":"Redd DS, Jensen JL, Hughes SJ, Pogue K, Sloan-Aagard CD, Miner DS. Effects of religious practice and teachings about sexual behavior on intent to vaccinate against human papillomavirus. Vaccines [Internet]. 2022;10(3):397.","journal-title":"Vaccines [Internet]"},{"issue":"16","key":"2669_CR108","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.vaccine.2013.02.026","volume":"31","author":"JD Grabenstein","year":"2013","unstructured":"Grabenstein JD. What the world\u2019s religions teach, applied to vaccines and immune globulins. Vaccine. 2013 Apr 12;31(16):2011\u201323.","journal-title":"Vaccine"},{"issue":"1","key":"2669_CR109","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/hast.1294","volume":"52","author":"MA Rothstein","year":"2022","unstructured":"Rothstein MA. Covid vaccine mandates and religious accommodation in employment. Hastings Cent Rep. 2022 Jan;52(1):8\u20139.","journal-title":"Hastings Cent Rep"},{"issue":"13","key":"2669_CR110","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1093\/ajhp\/zxae031","volume":"81","author":"KM Durant","year":"2024","unstructured":"Durant KM, Whitesell A, Dasse KD. A review of fetal cell lines used during drug development: focus on COVID-19 vaccines, transplant medications, and biologics. Am J Health Syst Pharm. 2024 Jul 1;81(13):e336\u201344.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"2669_CR111","doi-asserted-by":"publisher","first-page":"e2023065483","DOI":"10.1542\/peds.2023-065483","volume":"153","author":"ST O\u2019Leary","year":"2024","unstructured":"O\u2019Leary ST, Opel DJ, Cataldi JR, Hackell JM. Strategies for improving vaccine communication and uptake. Pediatrics. 2024 Mar 1;153(3):e2023065483.","journal-title":"Pediatrics"},{"issue":"1","key":"2669_CR112","doi-asserted-by":"publisher","first-page":"2190716","DOI":"10.1080\/21645515.2023.2190716","volume":"19","author":"AR Alsuwaidi","year":"2023","unstructured":"Alsuwaidi AR, Hammad HA, Elbarazi I, Sheek-Hussein M. Vaccine hesitancy within the Muslim community: islamic faith and public health perspectives. Hum Vaccines Immunotherapeutics. 2023 Jan 2;19(1):2190716.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"11\u201312","key":"2669_CR113","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0264-410X(02)00627-8","volume":"21","author":"T May","year":"2003","unstructured":"May T, Silverman RD. \u2018Clustering of exemptions\u2019 as a collective action threat to herd immunity. Vaccine. 2003 Mar 7;21(11\u201312):1048\u201351.","journal-title":"Vaccine"},{"issue":"1","key":"2669_CR114","doi-asserted-by":"publisher","first-page":"39","DOI":"10.18820\/23099089\/actat.v42i1.4","volume":"42","author":"VU Iheanacho","year":"2022","unstructured":"Iheanacho VU. Christianity and medical science: a historical quest for remedy in time of epidemics. Acta Theol. 2022 Jun 24;42(1):39\u201358.","journal-title":"Acta Theol"},{"issue":"4","key":"2669_CR115","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/dewb.12372","volume":"23","author":"R Zach","year":"2023","unstructured":"Zach R, Bentwich ME. Reasons for and insights about HPV vaccination refusal among ultra-Orthodox Jewish mothers. Dev World Bioeth. 2023 Dec;23(4):300\u201311.","journal-title":"Dev World Bioeth"},{"issue":"Suppl 1","key":"2669_CR116","first-page":"S17","volume":"7","author":"S Hamdi","year":"2017","unstructured":"Hamdi S. The impact of teachings on sexuality in Islam on HPV vaccine acceptability in the Middle East and North Africa region. J Epidemiol Glob Health. 2017 Jan;7(Suppl 1):S17\u201322.","journal-title":"J Epidemiol Glob Health"},{"key":"2669_CR117","first-page":"B058","volume-title":"Cancer epidemiology, biomarkers & prevention","author":"A Namoos","year":"2023","unstructured":"Namoos A, Abdelkarim M, Abosumak N, Ramadan D, Ramadan R, Sheppard VB, Gal T. Abstract B058: cervical cancer prevention hesitancy comparison between Muslim and Non-Muslim American women: qualitative study. In: Cancer epidemiology, biomarkers & prevention. Vol. 32, No. 1_Supplement. The American Association for Cancer Research; 2023 Jan 1. p. B058\u2013058."},{"key":"2669_CR118","doi-asserted-by":"crossref","unstructured":"Kaaria F, Odhiambo FB, Okenyoru DS, Murugi L, Matoke VO, Salima R, Anyika D, Ogutu G, Musau A. Religious leaders\u00b4 willingness to promote the uptake of human papillomavirus vaccine among their congregants in Mavoko Sub-County, Machakos County, Kenya. Pan Afr Med J. 2024;48(1).","DOI":"10.11604\/pamj.2024.48.141.43492"},{"issue":"4","key":"2669_CR119","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.pedhc.2023.01.002","volume":"37","author":"A Washington","year":"2023","unstructured":"Washington A, Chabaan J, Fakih A, Ford S, Rutledge L, Lilly J, Herrera MY, Kim Y, Thompson HS. \u201cWhy is it so necessary?\u201d: African American parents\u2019 perspectives on delaying and refusing HPV vaccination. J Pediatr Health Care. 2023 Jul 1;37(4):373\u201380.","journal-title":"J Pediatr Health Care"},{"key":"2669_CR120","unstructured":"DESA U. State of the World\u2019s indigenous peoples: indigenous peoples. Access Health Serv."},{"issue":"3","key":"2669_CR121","first-page":"437","volume":"35","author":"S Bedi","year":"2024","unstructured":"Bedi S, Strachan R, Zehbe I. Awareness of human papillomavirus infection among indigenous males in North America and Oceania: a scoping review. Cancer Cause Control. 2024 Mar;35(3):437\u201349.","journal-title":"Cancer Cause Control"},{"issue":"11","key":"2669_CR122","doi-asserted-by":"publisher","first-page":"E381","DOI":"10.1503\/cmaj.210112","volume":"193","author":"I Mosby","year":"2021","unstructured":"Mosby I, Swidrovich J. Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada. Cmaj. 2021 Mar 15;193(11):E381\u20133.","journal-title":"Cmaj"},{"issue":"1","key":"2669_CR123","doi-asserted-by":"publisher","first-page":"e0001406","DOI":"10.1371\/journal.pgph.0001406","volume":"3","author":"SE MacDonald","year":"2023","unstructured":"MacDonald SE, Kenzie L, Letendre A, Bill L, Shea-Budgell M, Henderson R, Barnabe C, Guichon JR, Colquhoun A, Ganshorn H, Bedingfield N. Barriers and supports for uptake of human papillomavirus vaccination in Indigenous people globally: a systematic review. PLOS Glob Public Health. 2023 Jan 6;3(1):e0001406.","journal-title":"PLOS Glob Public Health"},{"issue":"6","key":"2669_CR124","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/ohn.664","volume":"170","author":"O Ayo-Ajibola","year":"2024","unstructured":"Ayo-Ajibola O, Davis RJ, Lin ME, West JD, Kokot NC, Chambers T. Associations between risk perception and HPV knowledge and vaccine uptake: highlighting the LGBTQ+ population. Otolaryngology-Head Neck Surg. 2024 Jun;170(6):1684\u201395.","journal-title":"Otolaryngology-Head Neck Surg"},{"issue":"9","key":"2669_CR125","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/jog.16049","volume":"50","author":"A Furuno","year":"2024","unstructured":"Furuno A, Sukegawa A, Ohshige K, Suzuki Y, Yamaguchi M, Miyagi E, Ueda Y, Sekine M, Mizushima T. Three-year questionnaire study on human papillomavirus vaccination targeting new female college school students: follow-up to a 2021 report to reveal the impact of a policy change in Japan. J Obstet Gynaecol Res. 2024 Sep;50(9):1640\u201348.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"2669_CR126","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5534\/wjmh.210262","volume":"41","author":"J Choi","year":"2022","unstructured":"Choi J, Kim S, Lee SJ, Bae S, Kim S. Human papillomavirus (HPV) vaccination intent among mothers of adolescent sons: a national survey on HPV knowledge, attitudes and beliefs in South Korea. World J Men\u2019s Health. 2022 May 4;41(2):413.","journal-title":"World J Men\u2019s Health"},{"key":"2669_CR127","doi-asserted-by":"publisher","first-page":"107327482412849","DOI":"10.1177\/10732748241284907","volume":"31","author":"LT Nguyen","year":"2024","unstructured":"Nguyen LT, Phan DQ, Gyan A, Nguyen HT, Cassell D, Huynh G. Parents\u2019 intentions of human papillomavirus vaccination for students in Vietnam: a cross-sectional study. Cancer Control. 2024 Sep 6;31:10732748241284907.","journal-title":"Cancer Control"},{"key":"2669_CR128","doi-asserted-by":"crossref","unstructured":"Habermacher C, Lallou\u00e9 B, Lamouille V, Thilly N, Agrinier N. Family physicians\u2019 practices and attitudes towards HPV vaccination since extension of HPV vaccination to males. Infect Dis Now. 2023 Apr 1;53(3):104669.","DOI":"10.1016\/j.idnow.2023.104669"},{"issue":"1","key":"2669_CR129","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1080\/13696998.2023.2282912","volume":"26","author":"C Palmer","year":"2023","unstructured":"Palmer C, Tobe K, Negishi Y, You X, Chen YT, Abe M. Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in Japan. J Med Econ. 2023 Dec 31;26(1):1546\u201354.","journal-title":"J Med Econ"},{"key":"2669_CR130","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s10900-019-00784-w","volume":"45","author":"J Jaiswal","year":"2020","unstructured":"Jaiswal J, LoSchiavo C, Maiolatesi A, Kapadia F, Halkitis PN. Misinformation, gendered perceptions, and low healthcare provider communication around HPV and the HPV vaccine among young sexual minority men in New York City: the P18 cohort study. J Commun Health. 2020 Aug;45:702\u201311.","journal-title":"J Commun Health"},{"issue":"3","key":"2669_CR131","doi-asserted-by":"publisher","first-page":"155798832412588","DOI":"10.1177\/15579883241258823","volume":"18","author":"KM Quist","year":"2024","unstructured":"Quist KM, Fontenot HB, Zimet G, Lim E, Matsunaga M, Liebermann E, Allen JD. HPV vaccine awareness, past behaviors, and future intentions among a diverse sample of fathers aged 27 to 45 years: a national survey. Am J Men\u2019s Health. 2024 Jun;18(3):15579883241258823.","journal-title":"Am J Men\u2019s Health"},{"issue":"4","key":"2669_CR132","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.acap.2022.01.008","volume":"22","author":"WY Kong","year":"2022","unstructured":"Kong WY, Huang Q, Thompson P, Grabert BK, Brewer NT, Gilkey MB. Recommending human papillomavirus vaccination at age, 9: a national survey of primary care professionals. Acad Pediatr. 2022 Jan 23;22(4):573\u201380.","journal-title":"Acad Pediatr"},{"key":"2669_CR133","first-page":"100315","volume":"14","author":"C Moucheraud","year":"2023","unstructured":"Moucheraud C, Whitehead HS, Songo J, Szilagyi PG, Hoffman RM, Kaunda-Khangamwa BN. Malawian caregivers\u2019 experiences with HPV vaccination for preadolescent girls: a qualitative study. Vaccine: X. 2023 Aug 1;14:100315.","journal-title":"Vaccine: X"},{"issue":"3","key":"2669_CR134","doi-asserted-by":"publisher","first-page":"2284359","DOI":"10.1080\/21645515.2023.2284359","volume":"19","author":"J Isher-Witt","year":"2023","unstructured":"Isher-Witt J, Foley S, Hassan A, Sloan A, Nkonga J, Fisher-Borne M. Age nine is possible: improving age 9 HPV initiation through a national quality improvement initiative during the COVID-19 pandemic. Hum Vaccines Immunotherapeutics. 2023 Dec 15;19(3):2284359.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"2669_CR135","doi-asserted-by":"crossref","unstructured":"Murciano-Gamborino C, Diez-Domingo J, Fons-Martinez J. Healthcare professionals\u2019 perspectives on HPV recommendations: themes of interest to different population groups and strategies for approaching them. Vaccines [Internet]. 2024 Jul 1;12(7):748. Available from: https:\/\/www.mdpi.com\/2076-393X\/12\/7\/748.","DOI":"10.3390\/vaccines12070748"},{"issue":"1","key":"2669_CR136","doi-asserted-by":"publisher","first-page":"2181610","DOI":"10.1080\/21645515.2023.2181610","volume":"19","author":"P Lake","year":"2023","unstructured":"Lake P, Fuzzell L, Brownstein NC, Fontenot HB, Michel A, McIntyre M, Whitmer A, Rossi SL, Perkins RB, Vadaparampil ST. HPV vaccine recommendations by age: a survey of providers in federally qualified health centers. Hum Vaccines Immunotherapeutics. 2023 Jan 2;19(1):2181610.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"4","key":"2669_CR137","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1071\/SH15097","volume":"12","author":"EP Chow","year":"2015","unstructured":"Chow EP, Fairley CK. A second peak in genital warts in later life suggests that behavioural factors explain a second peak in human papillomavirus prevalence in older women. Sexual Health. 2015 Jun 22;12(4):277\u201378.","journal-title":"Sexual Health"},{"issue":"1","key":"2669_CR138","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ygyno.2020.08.034","volume":"160","author":"G Bogani","year":"2021","unstructured":"Bogani G, Raspagliesi F, di Donato V, Brusadelli C, Guerrisi R, Pinelli C, Casarin J, Ghezzi F, Del Fabro A, Ditto A, Simoncini T. Spotlight on the role of human papillomavirus vaccines. Gynecologic Oncol. 2021 Jan 1;160(1):346\u201350.","journal-title":"Gynecologic Oncol"},{"issue":"5","key":"2669_CR139","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.vaccine.2019.11.073","volume":"38","author":"C Constable","year":"2020","unstructured":"Constable C, Caplan A. Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: implications for future vaccines. Vaccine. 2020 Jan 29;38(5):954\u201362.","journal-title":"Vaccine"},{"issue":"20","key":"2669_CR140","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.vaccine.2021.04.003","volume":"39","author":"V Daniels","year":"2021","unstructured":"Daniels V, Saxena K, Roberts C, Kothari S, Corman S, Yao L, Niccolai L. Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysis. Vaccine. 2021 May 12;39(20):2731\u201335.","journal-title":"Vaccine"},{"issue":"5","key":"2669_CR141","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/AOG.0b013e31818b0df2","volume":"112","author":"ST Lindau","year":"2008","unstructured":"Lindau ST, Drum ML, Gaumer E, Surawska H, Jordan JA. Prevalence of high-risk human papillomavirus among older women. Obstet Gynecol. 2008 Nov;112(5):979\u201389.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2669_CR142","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1186\/s12889-024-19485-8","volume":"24","author":"K Coursey","year":"2024","unstructured":"Coursey K, Muralidhar K, Srinivas V, Jaykrishna P, Begum F, Ningaiah N, Lee SJ, Madhivanan P. Acceptability of HPV vaccination for cervical cancer prevention amongst emerging adult women in rural Mysore, India: a mixed-methods study. BMC Public Health. 2024 Aug 7;24(1):2139.","journal-title":"BMC Public Health"},{"key":"2669_CR143","first-page":"1","volume-title":"BMC proceedings","author":"DE Waheed","year":"2021","unstructured":"Waheed DE, Schiller J, Stanley M, Franco EL, Poljak M, Kjaer SK, Del Pino M, van der Klis F, Schim van der Loeff MF, Baay M, Van Damme P. Human papillomavirus vaccination in adults: impact, opportunities and challenges-a meeting report. In: BMC proceedings. BioMed Central; 2021 Aug, vol. 15, p. 1\u201315."},{"issue":"9961","key":"2669_CR144","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/S0140-6736(14)61230-7","volume":"384","author":"PE Castle","year":"2014","unstructured":"Castle PE, Schmeler KM. HPV vaccination: for women of all ages? Lancet. 2014 Dec 20;384(9961):2178\u201380.","journal-title":"Lancet"},{"issue":"45","key":"2669_CR145","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.1016\/j.vaccine.2023.09.054","volume":"41","author":"M Dionne","year":"2023","unstructured":"Dionne M, Sauvageau C, Kiely M, Rathwell M, Bandara T, Neudorf C, Dub\u00e9 \u00c8. \u201cThe problem is not lack of information\u201d: a qualitative study of parents and school nurses\u2019 perceptions of barriers and potential solutions for HPV vaccination in schools. Vaccine. 2023 Oct 26;41(45):6654\u201360.","journal-title":"Vaccine"},{"issue":"3","key":"2669_CR146","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/v15030778","volume":"15","author":"L Dufour","year":"2023","unstructured":"Dufour L, Carrouel F, Dussart C. Human papillomaviruses in adolescents: knowledge, attitudes, and practices of pharmacists regarding virus and vaccination in France. Viruses. 2023 Mar 17;15(3):778.","journal-title":"Viruses"},{"key":"2669_CR147","doi-asserted-by":"publisher","first-page":"1403634","DOI":"10.3389\/fpubh.2024.1403634","volume":"12","author":"DI Fallatah","year":"2024","unstructured":"Fallatah DI, Khalil MA, Abd ElHafeez S, Gouda S, Alshanbari HM, Awadalla M, Ahram M, Alosaimi B. Factors influencing human papillomavirus vaccine uptake among parents and teachers of schoolgirls in Saudi Arabia: a cross-sectional study. Front Public Health. 2024 Oct 16;12:1403634.","journal-title":"Front Public Health"},{"key":"2669_CR148","doi-asserted-by":"crossref","unstructured":"Bhoopathi V, Fellows JL, Glenn B, Bastani R, Atchison KA. Los Angeles County dentists\u2019 opinions on discussing human papilloma virus-related oral health issues and recommending vaccine to patients. Hum Vaccin Immunotherapeutics [Internet]. 2024 Jul 3;20(1). [cited 2025 Jan 4]; Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11225912\/#t0002.","DOI":"10.1080\/21645515.2024.2371671"},{"issue":"2","key":"2669_CR149","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/ijerph19020790","volume":"19","author":"T Cantile","year":"2022","unstructured":"Cantile T, Leuci S, Blasi A, Coppola N, Sorrentino R, Ferrazzano GF, et al. Human papilloma virus vaccination and oropharyngeal cancer: knowledge, perception and attitude among Italian pediatric dentists. Int J Environ Res Pub Health. 2022 Jan 11;19(2):790\u20130.","journal-title":"Int J Environ Res Pub Health"},{"issue":"8","key":"2669_CR150","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.31557\/APJCP.2022.23.8.2719","volume":"23","author":"VK Vieira","year":"2022","unstructured":"Vieira VK, Wendt GW, Ferreto LE, Pascotto CR, Lucio LC. University Students\u2019 knowledge about the relation between human papillomavirus (HPV) and Head and Neck and oral cancers. Asian Pac J Cancer Prev: APJCP. 2022 Aug;23(8):2719.","journal-title":"Asian Pac J Cancer Prev: APJCP"},{"issue":"2","key":"2669_CR151","doi-asserted-by":"publisher","first-page":"2219185","DOI":"10.1080\/21645515.2023.2219185","volume":"19","author":"A Fernandes","year":"2023","unstructured":"Fernandes A, Wang D, Domachowske JB, Suryadevara M. HPV vaccine knowledge, attitudes, and practices among New York State medical providers, dentists, and pharmacists. Hum Vaccines Immunotherapeutics. 2023 Aug;19(2):2219185. https:\/\/doi.org\/10.1080\/21645515.2023.2219185. PMID: 37340826; PMCID: PMC10286660.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"14","key":"2669_CR152","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1002\/cam4.3192","volume":"9","author":"J Fokom Domgue","year":"2020","unstructured":"Fokom Domgue J, Cunningham SA, Yu RK, Shete S. Reasons for not receiving the HPV vaccine among eligible adults: lack of knowledge and of provider recommendations contribute more than safety and insurance concerns. Cancer Med. 2020 Jul;9(14):5281\u201390.","journal-title":"Cancer Med"},{"issue":"4","key":"2669_CR153","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/her\/cyac016","volume":"37","author":"AR Richman","year":"2022","unstructured":"Richman AR, Torres E, Wu Q, Eldridge D, Lawson L. HPV vaccine recommendation practices of current and future physicians in North Carolina: an exploratory study. Health Educ Res. 2022 Aug 1;37(4):213\u201326.","journal-title":"Health Educ Res"},{"key":"2669_CR154","first-page":"101772","volume":"27","author":"LP Brennan","year":"2022","unstructured":"Brennan LP, Rodriguez NM, Head KJ, Zimet GD, Kasting ML. Obstetrician\/Gynecologists\u2019 HPV vaccination recommendations among women and girls 26 and younger. Preventative Med Rep. 2022 Jun 1;27:101772.","journal-title":"Preventative Med Rep"},{"issue":"7","key":"2669_CR155","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/08901171221091438","volume":"36","author":"R Btoush","year":"2022","unstructured":"Btoush R, Kohler RK, Carmody DP, Hudson SV, Tsui J. Factors that influence healthcare provider recommendation of HPV vaccination. Am J Health Promot. 2022 Sep;36(7):1152\u201361.","journal-title":"Am J Health Promot"},{"issue":"1","key":"2669_CR156","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10865-022-00284-8","volume":"46","author":"M AuYoung","year":"2023","unstructured":"AuYoung M, Rodriguez Espinosa P, Chen WT, Juturu P, Young ME, Casillas A, Adkins-Jackson P, Hopfer S, Kissam E, Alo AK, Vargas RA. Addressing racial\/ethnic inequities in vaccine hesitancy and uptake: lessons learned from the California alliance against COVID-19. J Behavioral Med. 2023 Apr;46(1):153\u201366.","journal-title":"J Behavioral Med"},{"key":"2669_CR157","unstructured":"Patel I, Benitez NM, Maxwell GL, Camacho FT, Balkrishnan R. HPV vaccination in the virginia context: demographic disparities, patient-provider gender concordance and the impact of changing recommendations. Va J Public Health. 5(2):4."},{"issue":"6","key":"2669_CR158","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/13557858.2017.1367761","volume":"24","author":"ND Hernandez","year":"2019","unstructured":"Hernandez ND, Daley EM, Young L, Kolar SK, Wheldon C, Vamos CA, Cooper D. HPV vaccine recommendations: Does a health care provider\u2019s gender and ethnicity matter to unvaccinated Latina college women? Ethn Health. 2019 Aug 18;24(6):645\u201361.","journal-title":"Ethn Health"},{"key":"2669_CR159","first-page":"102126","volume":"32","author":"S Al Sad","year":"2023","unstructured":"Al Sad S, Pandit R, Alhashim N, Abdel-Rasoul M. Primary care providers\u2019 approaches to cervical cancer screening in Muslim females. Preventative Med Rep. 2023 Apr 1;32:102126.","journal-title":"Preventative Med Rep"},{"issue":"6","key":"2669_CR160","doi-asserted-by":"publisher","first-page":"2132755","DOI":"10.1080\/21645515.2022.2132755","volume":"18","author":"I Osaghae","year":"2022","unstructured":"Osaghae I, Darkoh C, Chido-Amajuoyi OG, Chan W, Wermuth PP, Pande M, Cunningham SA, Shete S. Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination. Hum Vaccines Immunotherapeutics. 2022 Nov 30;18(6):2132755.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"12","key":"2669_CR161","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3390\/healthcare11121702","volume":"11","author":"MA Xu","year":"2023","unstructured":"Xu MA, Choi J, Capasso A, DiClemente R. Patient-provider health communication strategies: enhancing HPV vaccine uptake among adolescents of color. In Healthcare. 2023 Jun 10;11(12):1702. MDPI.","journal-title":"In Healthcare"},{"key":"2669_CR162","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s10903-018-0709-6","volume":"20","author":"E McComb","year":"2018","unstructured":"McComb E, Ramsden V, Olatunbosun O, Williams-Roberts H. Knowledge, attitudes and barriers to human papillomavirus (HPV) vaccine uptake among an immigrant and refugee catch-up group in a Western Canadian province. J Immigr Minor Health. 2018 Dec;20:1424\u201328.","journal-title":"J Immigr Minor Health"},{"issue":"7","key":"2669_CR163","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/vaccines9070713","volume":"9","author":"C Lin","year":"2021","unstructured":"Lin C, Mullen J, Smith D, Kotarba M, Kaplan SJ, Tu P. Healthcare providers\u2019 vaccine perceptions, hesitancy, and recommendation to patients: a systematic review. Vaccines. 2021 Jul 1;9(7):713.","journal-title":"Vaccines"},{"issue":"35","key":"2669_CR164","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1016\/j.vaccine.2016.06.037","volume":"34","author":"CL Scherr","year":"2016","unstructured":"Scherr CL, Augusto B, Ali K, Malo TL, Vadaparampil ST. Provider-reported acceptance and use of the centers for disease control and prevention messages and materials to support HPV vaccine recommendation for adolescent males. Vaccine. 2016 Jul 29;34(35):4229\u201334.","journal-title":"Vaccine"},{"key":"2669_CR165","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10900-010-9255-4","volume":"35","author":"EL McCave","year":"2010","unstructured":"McCave EL. Influential factors in HPV vaccination uptake among providers in four states. J Commun Health. 2010 Dec;35:645\u201352.","journal-title":"J Commun Health"},{"issue":"7","key":"2669_CR166","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1080\/14760584.2022.2056026","volume":"21","author":"P Verger","year":"2022","unstructured":"Verger P, Botelho-Nevers E, Garrison A, Gagnon D, Gagneur A, Gagneux-Brunon A, Dub\u00e9 E. Vaccine hesitancy in health-care providers in Western countries: a narrative review. Expert Rev Vaccines. 2022 Jul 3;21(7):909\u201327.","journal-title":"Expert Rev Vaccines"},{"key":"2669_CR167","volume-title":"Development and evaluation of a nurse leader-driven electronic clinical reminder and its impact on documentation of the importance of vaccines among primary care patients","author":"D Schweitzer","year":"2023","unstructured":"Schweitzer D. Development and evaluation of a nurse leader-driven electronic clinical reminder and its impact on documentation of the importance of vaccines among primary care patients. Wilmington University (Delaware); 2023."},{"issue":"5","key":"2669_CR168","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/infdis\/jiad055","volume":"228","author":"JL White","year":"2023","unstructured":"White JL, Grabowski MK, Rositch AF, Gravitt PE, Quinn TC, Tobian AA, Patel EU. Trends in adolescent human papillomavirus vaccination and parental hesitancy in the United States. J Infect Dis. 2023 Sep 1;228(5):615\u201326.","journal-title":"J Infect Dis"},{"issue":"5","key":"2669_CR169","doi-asserted-by":"publisher","first-page":"kad068","DOI":"10.1093\/jncics\/pkad068","volume":"7","author":"M Chandra","year":"2023","unstructured":"Chandra M, Osaghae I, Talluri R, Shete S. Barriers to human papillomavirus vaccine uptake: role of state religiosity and healthcare professionals\u2019 participation in a state vaccine program. JNCI Cancer Spectr. 2023 Oct 1;7(5):kad068.","journal-title":"JNCI Cancer Spectr"},{"issue":"12","key":"2669_CR170","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/15265161.2020.1833098","volume":"20","author":"A Rattani","year":"2020","unstructured":"Rattani A. Methodological clarity in religious perspectives of bioethical issues: lessons from Islamic studies. Am J Bioethics. 2020 Dec 1;20(12):40\u201342.","journal-title":"Am J Bioethics"},{"issue":"1","key":"2669_CR171","first-page":"1","volume":"1","author":"C Davies","year":"2019","unstructured":"Davies C. Bioethics human papillomavirus and HPV vaccine. J Regen Biol Med. 2019;1(1):1\u20133.","journal-title":"J Regen Biol Med"}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02669-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-025-02669-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02669-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:55:24Z","timestamp":1781614524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12939-025-02669-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":171,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2669"],"URL":"https:\/\/doi.org\/10.1186\/s12939-025-02669-y","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}